ADHD Statistics in Michigan

Comprehensive ADHD statistics for Michigan, including prevalence, demographics, treatment access, and outcomes data.

3 min read
9.2%[1]
of children in Michigan have a current ADHD diagnosis

This figure, based on caregiver reports from 2018-2019, highlights the significant number of young people in the state managing this condition.

2018–2019

Key Takeaways on ADHD in Michigan

  • Michigan's child ADHD prevalence rate is 9.2%, slightly below the national lifetime diagnosis rate of 11.4%.9.2%[1]
  • The state shows a high reliance on medication-only treatment for children with ADHD, with 52.5% receiving only medication, compared to the national average of 43.3%.52.5%[3]
  • Michigan ranks 35th nationally for youth mental health measures, indicating a significant gap between the needs of children and the availability of resources.35th[5]
  • Access to care is a major challenge, with a statewide ratio of one mental health clinician for every 330 people and caregivers reporting long wait times and poor care coordination.1:330[6]
  • Nationally, there has been a dramatic surge in adult ADHD diagnoses since the COVID-19 pandemic, with monthly incidence rates nearly quadrupling from pre-pandemic levels.3.95x[4]
  • A significant treatment gap exists, as nearly 30% of U.S. children with a current ADHD diagnosis receive no specific medication or behavioral therapy.~30%[2]
  • Post-pandemic, women have accounted for approximately 60% of new adult ADHD diagnoses, reflecting a 'catching-up effect' due to better recognition of inattentive symptoms.60%[4]

Understanding ADHD Prevalence in Michigan

Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder affecting both children and adults. Tracking its prevalence is crucial for allocating healthcare resources, developing educational support systems, and understanding public health needs. In Michigan, the rate of ADHD diagnosis provides a snapshot of the condition's impact on families across the state, while also highlighting areas where access to diagnosis and care may vary.

ADHD Prevalence: Michigan and U.S. Overview

10.6%[7]
of Michigan children have ever received an ADHD diagnosis

This lifetime prevalence is slightly lower than the national average.

~4%[8]
Estimated prevalence of ADHD among adults in Michigan

This conservative estimate suggests as many as 280,000 adults in the state may be contending with ADHD symptoms.

2023
6.0%[9]
of U.S. adults report a current ADHD diagnosis

This amounts to an estimated 15.5 million adults nationwide.

Regional Disparities Within Michigan

ADHD prevalence is not uniform across Michigan. Significant variations exist between different regions, which can be influenced by factors like provider density, socioeconomic conditions, and access to diagnostic services in urban versus rural areas[10]. These disparities underscore the challenges many families face in getting consistent and timely care depending on where they live in the state[1].

ADHD Prevalence Varies Across Michigan Regions

Child ADHD Prevalence Rate
7.3%
St. Joseph & Muskegon Regions
4.6%
Dearborn Hospital Referral Region
Rates in some regions are over 58% higher than in others
This variation suggests that access to specialized diagnostic services may be unevenly distributed across the state, impacting how many children are formally identified and receive support.

The Landscape of ADHD Treatment and Access to Care

Effective management of ADHD often requires a comprehensive, multi-modal approach that combines medication with behavioral therapy. Clinical guidelines recommend this integrated strategy to address both the core symptoms of ADHD and the behavioral challenges that can accompany it[11]. However, data from Michigan reveals a significant reliance on medication, suggesting potential barriers to accessing comprehensive therapeutic services for many families.

Barriers to Comprehensive Care

Even when a diagnosis is made, many families in Michigan struggle to access the full spectrum of recommended care. Systemic issues, including a shortage of mental health professionals, create significant hurdles[8]. Caregivers frequently report delays in getting referrals, long waiting periods for appointments, and poor coordination between healthcare providers and schools[1]. These challenges are compounded by stigma and a lack of awareness, which can prevent families from seeking help in the first place.

The high rate of medication-only treatment in Michigan may point to systemic barriers in accessing behavioral therapy, which is a critical component of care, especially for younger children.

Demographic Shifts in ADHD Diagnosis

The demographics of ADHD are evolving. While historically diagnosed more often in boys, there is now a recognized “catching-up effect” among adult women[16]. This is largely attributed to a better understanding of how ADHD presents differently across genders, particularly the inattentive subtype, which is more common in females[4]. Age is also a significant factor, with prevalence being highest among young adults.

ADHD Demographics: Gender and Age Disparities

Monthly Growth in Adult ADHD Incidence During Pandemic
6.7%
Females
3.3%
Males
The rate of new diagnoses grew more than twice as fast in women than in men.
This rapid growth reflects increased recognition of inattentive ADHD symptoms, which are more prevalent in females and were historically overlooked.
ADHD Prevalence by Age (U.S. Adults)
21.7%
Ages 18–24
4.9%
Ages 65+
Young adults have a prevalence rate over four times higher than seniors.
This highlights a critical period for diagnosis and support during the transition to adulthood, college, and career.

Co-occurring Conditions and Long-Term Outcomes

ADHD frequently coexists with other mental health conditions and substance use disorders (SUD). Individuals with a history of other mental health diagnoses or SUD have significantly higher rates of ADHD, complicating treatment and support[4]. When left untreated, ADHD can lead to serious long-term consequences, including academic underachievement, occupational difficulties, and an increased risk for depression and anxiety[8].

ADHD and Comorbidity

ADHD incidence in adults with a history of substance use disorder (pre-pandemic)

This strong correlation highlights the need for integrated treatment for co-occurring conditions.

PubMed Central (2020)
5x Higher[4]
Post-pandemic, new ADHD diagnoses grew faster in people without a history of SUD

This suggests that increased awareness is reaching a broader population beyond those already engaged with the mental health system.

PubMed Central (2020)
Narrowing Gap[4]

Frequently Asked Questions

Sources & References

All statistics and claims on this page are supported by peer-reviewed research and official government data sources.

1NSCH 2018 19: Prevalence of ADD or ADHD, Michigan. Nschdata. Published 2022. Accessed January 2026. https://www.nschdata.org/browse/survey/results?q=7815&r=24
2Data and Statistics on ADHD - CDC. Centers for Disease Control and Prevention. Published 2022. Accessed January 2026. https://www.cdc.gov/adhd/data/index.html
3Child ADHD in Michigan: Prevalence, medication & therapy. Chrt. Accessed January 2026. https://chrt.org/publication/child-adhd-michigan/
4Trends of incident adult Attention-deficit/hyperactivity .... PubMed Central. Published 2020. PMC12630555. Accessed January 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC12630555/
5Key F. State Summaries Michigan | 2023 Annual Report | AHR. Americashealthrankings. Published 2018. Accessed January 2026. https://www.americashealthrankings.org/publications/reports/2023-annual-report/state-summaries-michigan
6[PDF] Michigan 2023 Uniform Reporting System Mental Health Data Results. Substance Abuse and Mental Health Services Administration. Published 2023. Accessed January 2026. https://www.samhsa.gov/data/sites/default/files/reports/rpt53125/Michigan.pdf
7Explore ADD/ADHD Treatment - Children in Michigan | AHR. Americashealthrankings. Accessed January 2026. https://www.americashealthrankings.org/explore/measures/ADDtreat_overall/MI
8Mental Health Statistics for Michigan 2023. Brightpinepsychology. Accessed January 2026. https://www.brightpinepsychology.com/mental-health-statistics-michigan/
9State-based Prevalence of ADHD Diagnosis and Treatment 2016 .... Centers for Disease Control and Prevention. Published 2020. Accessed January 2026. https://www.cdc.gov/adhd/data/state-based-prevalence-of-adhd-diagnosis-and-treatment-2016-2019.html
10Zgodic A. County-Level Prevalence Estimates of ADHD in Children in .... PubMed Central. Published 2023. PMC10099151. Accessed January 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC10099151/
11Prevalence E. State-based Prevalence of ADHD Diagnosis and Treatment 2016 .... Centers for Disease Control and Prevention. Published 2020. Accessed January 2026. https://www.cdc.gov/adhd/data/state-based-prevalence-of-adhd-diagnosis-and-treatment-2016-2019.html
12[PDF] ACCESS TO BEHAVIORAL HEALTH CARE IN MICHIGAN, 2019 .... Mihealthfund. Published 2022. Accessed January 2026. https://mihealthfund.org/wp-content/uploads/2022/12/Health-Fund-2022-Behavior-Health-Access-Study-1.pdf
13ADHD | NAMI Michigan. Namimi. Accessed January 2026. https://namimi.org/mental-illness/adhd
14General P. General Prevalence of ADHD in Adults - CHADD. Chadd. Accessed January 2026. https://chadd.org/about-adhd/general-prevalence-adults/
15State-Level Estimates of the Prevalence of Parent-Reported ADHD .... PubMed Central. PMC9489617. Accessed January 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC9489617/
16ADHD Incidence Increased Among Adults From 2020 to 2023. Sleepwakeadvisor. Published 2016. Accessed January 2026. https://www.sleepwakeadvisor.com/news/adhd-incidence-increased-among-adults-from-2020-to-2023/
17Attention-Deficit/Hyperactivity Disorder (ADHD). National Institute of Mental Health. Accessed January 2026. https://www.nimh.nih.gov/health/statistics/attention-deficit-hyperactivity-disorder-adhd
18Commentary on Sources of Attention-Deficit/Hyperactivity .... PubMed Central. Published 2024. PMC12469559. Accessed January 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC12469559/